<?xml version="1.0" encoding="UTF-8"?>
<Label drug="ciprodex" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

  In Phases II and III clinical trials, a total of 937 patients were treated with CIPRODEX(r) Otic. This included 400 patients with acute otitis media with tympanostomy tubes and 537 patients with acute otitis externa. The reported treatment-related adverse events are listed below:



   Acute Otitis Media in pediatric patients with tympanostomy tubes  



 The following treatment-related adverse events occurred in 0.5% or more of the patients with non-intact tympanic membranes.




 Adverse Event                                                       Incidence (N=400)                    
  
 Ear discomfort                                                             3.0%                          
 Ear pain                                                                   2.3%                          
 Ear precipitate(residue)                                                   0.5%                          
 Irritability                                                               0.5%                          
 Taste perversion                                                           0.5%                          
        The following treatment-related adverse events were each reported in a single patient: tympanostomy tube blockage; ear pruritus; tinnitus; oral moniliasis; crying; dizziness; and erythema.
 

   Acute Otitis Externa  



 The following treatment-related adverse events occurred in 0.4% or more of the patients with intact tympanic membranes.




 Adverse Event                                                       Incidence (N=537)                    
  
 Ear pruritus                                                               1.5%                          
 Ear debris                                                                 0.6%                          
 Superimposed earinfection                                                  0.6%                          
 Ear congestion                                                             0.4%                          
 Ear pain                                                                   0.4%                          
 Erythema                                                                   0.4%                          
        The following treatment-related adverse events were each reported in a single patient: ear discomfort; decreased hearing; and ear disorder (tingling).
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
